US 2013/0295167 A1Published application

Enhanced immune response in bovine species

AssigneeBayer Intellectual Property GmbH

InventorsAlbert Abraham, Daniel Keil, Jason Nickell, Christian Weiss

Life of this patent

Estimating the term…

Abstract

The present invention relates to a method of immune activation which is effective for eliciting a non-antigen-specific immune response in a member of the bovine species. The method is particularly effective for protecting a member of the bovine species from infectious disease and treating animals inflicted with infectious disease.

Claims11

Dependent claims

An immunomodulator composition, wherein the immunomodulator composition comprises:

a. a cationic liposome delivery vehicle;
and
b. a nucleic acid molecule
for treating bovine respiratory disease in cattle.

1 more element

Dependencies are inferred from the claim text.

Facts

Application: 13/995,960Filed 20 Dec 2011
Priority: 22 Dec 2010
Published: 7 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 31/711
Compounds having three or more nucleosides or nucleotides: natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to…
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/1272
Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers: comprising non-phosphatidyl surfactants as…
A61K 39/102
Bacterial antigens: pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Family

Application61/426,255Us provisional application · filed 22 Dec 2010
US 2013/0295167 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results